Intentar ORO - Gratis
Hybrid funds are best suited to handle current market volatility
Mint New Delhi
|January 29, 2025
Hybrid funds have well-balanced portfolios to take advantage of the best of all asset groups, say experts
With corporate earnings growth tapering and global headwinds strengthening, hybrid funds offer the best risk-adjusted returns to investors, said market experts at Mint's 17th BFSI Summit in Mumbai.
Hybrid funds have well-balanced portfolios of debt and equity to take advantage of the best of all asset groups, the experts said, adding that investors should temper their equity return expectations as volatility will be a persistent theme in the medium term.
"Over a span of three or four decades, around 25% of the times equities have underperformed assets like bonds, returning less than 7-8% annually, particularly during times of volatility," Kalpen Parekh, managing director and chief executive of DSP Mutual Fund, said at the summit.
The benchmark Nifty 50 index returned only about 9% in 2024, much lower than 2023's 19%. After a post-covid bull run for three years, investors felt the tremors of a volatile market in 2024 as corporate earnings growth started slowing in the second half of the year. Lower government spending, moderating household credit, sticky inflation and slow urban consumption hit corporate earnings for the better part of 2024-25.
Esta historia es de la edición January 29, 2025 de Mint New Delhi.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Mint New Delhi

Mint New Delhi
How CCI plans to watch AI use by companies
The Competition Commission of India (CCI) on Monday proposed a self-audit for companies to keep track of how they use artificial intelligence (AI) and the data they train AI models on. Implementing such a practice comes with multiple caveats. Mint explains.
2 mins
October 08, 2025

Mint New Delhi
NAVIGATING A JOB LOSS IS NOT AS HARD AS IT SEEMS, BUT YOU SHOULD START EARLY
The best time to mend the roof is when the sun is shining, not after the rains commence. There is so much wisdom in this one sentence that it needs careful reflection. People expect life to be a smooth, sedate, upward ride, but it is anything but that. In fact, every facet of life has its ups and downs - sometimes, they are positive and at other times, they may be challenging.
3 mins
October 08, 2025
Mint New Delhi
US TARIFF-LED RISKS PERSIST FOR INDIA
The Indian economy stumbled in August, hit by the US's additional 25% tariffs on top of the 25% reciprocal levy, as external risks weighed on domestic momentum through a weakening rupee, continued selling by foreign investors, sliding stock market and slowing exports.
3 mins
October 08, 2025
Mint New Delhi
Nykaa fashion arm sashays again—spotlight on the stride
The fashion business of FSN E-Commerce Ventures Ltd (Nykaa) is showing signs of revival after several quarters of modest performance.
1 mins
October 08, 2025

Mint New Delhi
‘RBI focusing on new use cases for e-rupee’
The Reserve Bank of India (RBI) is in no rush to open up the pilots for the central bank digital currency (CBDC) to the masses and is, instead, focusing on adding more use cases to the e-rupee with a focus on cross-border transactions, T. Rabi Sankar, deputy governor of the central bank, said on Tuesday.
1 mins
October 08, 2025
Mint New Delhi
Nobel physics prize goes to pioneers of quantum mechanics
US-based scientists John Clarke, Michel Devoret and John Martinis won the 2025 Nobel Prize in Physics for “experiments that revealed quantum physics in action”, paving the way for the development of the next generation of digital technologies.
1 min
October 08, 2025
Mint New Delhi
Nvidia to continue sponsoring H-1B visas
Chipmaker Nvidia's CEO Jensen Huang said that the company will continue to sponsor H-IB visas and cover all associated costs following U.S. President Donald Trump's executive order last month that imposed a $100,000 fee on each new application, Business Insider reported on Tuesday.
1 min
October 08, 2025
Mint New Delhi
AstraZeneca to sell cancer drug in India
AstraZeneca Pharma on Tuesday said it has received approval from the national drug regulator to market a cancer treatment drug in the country.
1 min
October 08, 2025
Mint New Delhi
Fintech lending growth slows after clampdown
But delinquency and deep-stage stress are still elevated, shows report
2 mins
October 08, 2025
Mint New Delhi
CENTRAL BANK OF INDIA RATED INDIA INVOLVED BY SKOCH FOR TRANSFORMING RECRUITMENT ONBOARDING DIGITALLY
The Central Bank of India has undertaken a landmark initiative to reimagine its recruitment and onboarding practices through a comprehensive digital solution.
1 mins
October 08, 2025
Listen
Translate
Change font size